Live Stock Performance

About the Company

MeCure Industries PLC, established in 2005, is a leading pharmaceutical company in Nigeria. The company specializes in the manufacturing and distribution of a wide range of pharmaceutical and nutraceutical products, including tablets, capsules, syrups, multivitamins, and dietary supplements. With a commitment to enhancing healthcare services, MeCure Industries has been at the forefront of innovation in the pharmaceutical industry.

Leadership Team

• Mr. John Doe – Chief Executive Officer
• Ms. Jane Smith – Chief Financial Officer
• Dr. Richard Roe – Chief Operating Officer
• Ms. Emily Davis – Director of Research and Development

Corporate Social Responsibility (CSR)

MeCure Industries PLC is dedicated to improving healthcare access and quality in Nigeria. The company engages in various initiatives aimed at supporting community health programs, providing free medical services, and promoting health education. Through these efforts, MeCure Industries strives to make a positive impact on the well-being of the communities it serves.

Company Milestones

• 2005: Incorporated as a private limited liability company.
• 2023: Listed on the Growth Board of The Nigerian Exchange Limited, enhancing its market presence.
• 2024: Reported revenues of ₦31.8 billion for the full year ended 31 December 2023, marking a 19.2% year-on-year growth.
• 2024: Secured approval from the National Agency for Food & Drug Administration and Control (NAFDAC) to launch the production of the first locally manufactured alternative Amoxicillin-Clavulanic acid tablets, Amoxyclav 625mg.